Skip to Content
Merck
All Photos(1)

Documents

S7705

Sigma-Aldrich

TRAPeze1X CHAPS Lysis Buffer

1X CHAPS Lysis Buffer is a component of the gel-and ELISA-based TRAPeze Telomerase Detection Kits & is used in the extraction step of the procedure.

Synonym(s):

CHAPS Lysis Buffer

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41116012
eCl@ss:
32160405
NACRES:
NA.32

Quality Level

manufacturer/tradename

Chemicon®

shipped in

wet ice

General description

1X CHAPS Lysis Buffer is a component of the gel- and ELISA-based TRAPeze Telomerase Detection Kits and is used in the extraction step of the procedure.
Used to supplement the TRAPEZE Kit assay when larger tissue samples necessitate additional 1X CHAPS Lysis Buffer for efficient cell lysis. It extends the capabilities of the kits by enabling the analysis of larger tissue samples.

Application

TRAPeze1X CHAPS Lysis Buffer has been used:
  • to extract total proteins from HEK293 cells in quantitative telomerase activity assay (Q-TRAP)
  • to homogenize mouse atrial tissues for western blots analysis
  • in telomerase expression analysis of cell lines to resuspend the cells to determine protein concentration

Storage and Stability

Store at 4°C.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
TRAPEZE is a trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Yu-Feng Hu et al.
Biochimica et biophysica acta. Molecular basis of disease, 1867(5), 166088-166088 (2021-01-31)
Point mutation in alcohol dehydrogenase 2 (ALDH2), ALDH2*2 results in decreased catalytic enzyme activity and has been found to be associated with different human pathologies. Whether ALDH2*2 would induce cardiac remodeling and increase the attack of atrial fibrillation (AF) remains

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service